Management of Chest Pain with Elevated Troponin

Initial Assessment and Diagnosis

The European Society of Cardiology recommends obtaining a 12-lead ECG within 10 minutes of patient arrival to emergency department or at first medical contact to determine if ST-segment elevation is present 3
The European Society of Cardiology suggests measuring cardiac troponin levels (preferably high-sensitivity cardiac troponin) as the preferred biomarker for detecting myocardial injury 3, 4
Serial troponin measurements are necessary (at 3 and 6 hours, and at an interval of 6-10 hours in-hospital) to exclude myocardial injury, as a normal initial troponin does not exclude MI, particularly within 6 hours of symptom onset 1, 5
The European Society of Cardiology recommends comparing with previous ECGs if available, as this provides valuable information for interpretation 3
Consider additional ECG leads (V7-V9, V3R, V4R) if standard leads are inconclusive and symptoms suggest ongoing ischemia 3

The European Society of Cardiology identifies high-risk features requiring urgent intervention, including recurrent or ongoing chest pain 6
Dynamic ST-segment changes (particularly ST depression or transient ST elevation) are also high-risk features 6, 7
Elevated troponin levels are a high-risk feature 6, 7
Hemodynamic instability is a high-risk feature 6
Major arrhythmias (repetitive ventricular tachycardia, ventricular fibrillation) are high-risk features 6
Diabetes mellitus is a high-risk feature 6
The European Society of Cardiology states that any detectable elevation of troponin in the setting of ischemic symptoms indicates myocardial infarction 1, 8
The risk of complications increases proportionally with the absolute level of troponin 1
Troponin serves as an independent predictor of patient risk 1
The 99th percentile of normal value provides the best predictive accuracy for elevated troponin 1, 9

The European Society of Cardiology recommends administering aspirin 75-150 mg daily for all patients with chest pain and elevated troponin 2, 6
Add clopidogrel (loading dose 300 mg followed by 75 mg daily) for all patients with chest pain and elevated troponin 2, 6
Initiate low-molecular-weight heparin (LMWH) or unfractionated heparin for all patients with chest pain and elevated troponin 2, 6
Start beta-blocker therapy (unless contraindicated) for all patients with chest pain and elevated troponin 2, 6
Provide oral or intravenous nitrates for persistent or recurrent chest pain 2, 6
For high-risk patients, continue LMWH while preparing for angiography 6
Administer glycoprotein IIb/IIIa receptor inhibitor to be continued for 12 hours (abciximab) or 24 hours (tirofiban, eptifibatide) after procedure if angioplasty is performed 6
Arrange coronary angiography as soon as possible (within 48 hours) for high-risk patients 6
For patients with severe ongoing ischemia, major arrhythmias, or hemodynamic instability, perform coronary angiography within the first hour 6

Elevated troponin is not always indicative of acute coronary syndrome - consider alternative causes such as myocarditis, pulmonary embolism, heart failure, or renal failure 1
In patients with borderline elevated troponin levels, obtain a careful clinical history before administering potent antithrombotic and antiplatelet agents that can cause bleeding 1, 5
Patients with ACS and elevated troponins derive greater benefit from treatment with GP IIb/IIIa inhibitors, LMWH, and early percutaneous coronary intervention than those without elevated troponin levels 1, 7
During the COVID-19 pandemic, mild troponin elevations (<2-3 times the upper limit of normal) in older patients with pre-existing cardiac disease may not require workup for type 1 MI unless strongly suggested clinically by angina chest pain and/or ECG changes 10
Point-of-care troponin testing can accelerate decision-making but may be less sensitive than central laboratory analyzers, potentially missing minor or modest elevations 1